Richard Dilorio Sells 20,000 Shares of InfuSystem Holdings, Inc. (NYSE:INFU) Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CEO Richard Dilorio sold 20,000 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $9.32, for a total transaction of $186,400.00. Following the transaction, the chief executive officer now directly owns 436,659 shares in the company, valued at $4,069,661.88. This trade represents a 4.38 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Richard Dilorio also recently made the following trade(s):

• On Wednesday, November 27th, Richard Dilorio sold 5,398 shares of InfuSystem stock. The shares were sold at an average price of $8.87, for a total transaction of $47,880.26.

InfuSystem Price Performance

Shares of INFU stock opened at $8.86 on Friday. The stock’s fifty day simple moving average is $7.29. InfuSystem Holdings, Inc. has a 1-year low of $5.74 and a 1-year high of $10.99. The stock has a market cap of $188.40 million, a P/E ratio of 147.67 and a beta of 1.45. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

Analyst Ratings Changes

A number of brokerages recently weighed in on INFU. B. Riley began coverage on InfuSystem in a research note on Thursday, September 26th. They set a “buy” rating and a $13.00 price objective for the company. StockNews.com upgraded shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 8th.

Institutional Investors Weigh In On InfuSystem

Large investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in InfuSystem by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 1,083,730 shares of the company’s stock worth $9,288,000 after purchasing an additional 18,432 shares in the last quarter. First Eagle Investment Management LLC raised its holdings in shares of InfuSystem by 10.0% in the second quarter. First Eagle Investment Management LLC now owns 666,048 shares of the company’s stock worth $4,549,000 after buying an additional 60,813 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of InfuSystem by 1.8% during the third quarter. Geode Capital Management LLC now owns 436,508 shares of the company’s stock worth $2,925,000 after buying an additional 7,550 shares during the period. State Street Corp grew its holdings in shares of InfuSystem by 1.1% during the third quarter. State Street Corp now owns 267,012 shares of the company’s stock valued at $1,789,000 after buying an additional 3,019 shares during the last quarter. Finally, Greenwood Capital Associates LLC increased its position in shares of InfuSystem by 14.0% in the 3rd quarter. Greenwood Capital Associates LLC now owns 119,062 shares of the company’s stock valued at $798,000 after acquiring an additional 14,587 shares during the period. Hedge funds and other institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.